Stocktoria
Kyverna Therapeutics, Inc. KYTX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-02-08
Kyverna Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 1,453,667 | $10.9M | 2.41% |
| MILLENNIUM MANAGEMENT LLC | 1,005,508 | $8.7M | 1.67% |
| D. E. Shaw & Co., Inc. | 721,581 | $6.2M | 1.19% |
| RENAISSANCE TECHNOLOGIES LLC | 367,492 | $3.2M | 0.61% |
| Point72 Asset Management, L.P. | 222,929 | $1.9M | 0.37% |
| TWO SIGMA INVESTMENTS, LP | 181,615 | $1.6M | 0.3% |
| CITADEL ADVISORS LLC | 87,626 | $756,212 | 0.15% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.